Glioblastoma-targeting peptide adsorbed on lipid nanocapsule surface: optimization of the process and targeting efficacy by C. Gazaille et al.
Glioblastoma-targeting peptide adsorbed on lipid
nanocapsule surface: optimization of the process and
targeting efficacy
Submitted by Claire Gazaille on Fri, 12/21/2018 - 11:49
Titre Glioblastoma-targeting peptide adsorbed on lipid nanocapsule surface: optimizationof the process and targeting efficacy
Type de
publication Communication
Type Communication sans actes dans un congrès
Année 2018
Langue Anglais
Date du
colloque 3-5/12/2018
Titre du
colloque SFNano
Auteur Gazaille, Claire [1], Akiki, Marthe [2], Franconi, Florence [3], Siegler, Benjamin [4],Eyer, Joël [5], Bastiat, Guillaume [6]
Pays France
Ville Montpellier
Résumé en
anglais
The current standard of care of glioblastoma (GBM): the highest grade brain tumor is
not a curative treatment and does not prevent high patient mortality (median survival
of 14 months, and 5-year survival rate lower than 10% (Stupp R et al., N. Engl. J.
Med, 2005; Stupp R et al., Lancet Oncol., 2009)). The scientific community must
address solutions to these unmet medical and patient needs and opportunities can be
found to develop innovative and complementary treatment to the standard
therapeutic scheme. The GLIOGEL project (ERA-NET Cofund EuroNanoMed III)
focuses on a hydrogel of GBM-targeting, drug-loaded lipid nanocapsules (LNCs). This
new drug delivey system will be implantable directly after GBM resection, and will
close the treatment gap until Stupp protocol (radiotherapy and/or adjuvant
chemotherapy, 4 to 6 weeks after resection). The sustained LNCs release will
specifically target the residual infiltrating GBM cells at resection border, main cause
of tumor recurrences. The proof of concept of adsorption of a targeting peptide: the
NFL-TBS.40-63 (NFL) at LNC surface was already done, with the specific targeting
property for GBM cells (Berges R et al., Mol. Ther., 2012 ; Balzeau J. et al.,
Biomaterials, 2013). So the first part of the project was to confirm and optimize the
association NFL-LNCs, and to show correlations regarding NFL and LNC
physicochemical properties.
 
LNCs in suspension with different sizes (from 30 to 100nm), surface charges
(positive, neutral and negative) and Span® 80 composition (from 0 to 15% w/wLNCs)
have been performed according to a phase inversion process (Heurtault et al.,
WO2001 / 064328, 2001). Different LNC concentrations (0.001 to 275mg/mL) were
incubated at room temperature for 12h with fixed NFL concentrations (50 to
200μg/mL). Free NFL proportions were quantified in the free NFL and NFL-adsorbed
LNC mixtures without prior separation, i.e. directly after incubation, to avoid all the
bias that can be observed using physical separations such as filtration by
centrifugation and dialysis. A Steric Exclusion Chromatography method was
developed for this purpose. Due to NFL properties (slightly positively charged and
capacity to form H-bond), we showed that the NFL adsorption at LNC surface was
enhanced with negatively charged LNCs, and when Span® 80 proportion at LNC
surface increase. These results were confirmed using two other methods without
prior separation: NMR diffusometry using the diffusion coefficients for both free and
adsorbed NFLs, and Fluorescence Correlation Spectroscopy using FITC-labeled NFL.
Other protein or peptide-adsorbed nanoparticles could be characterized using these
three methods, and the absence of physical separation before the quantification is a
real benefit for the accuracy and veracity of data. Finally, the best LNC candidates
with total NFL adsorption were tested on a large library of GBM cell lines, with
different incubation times in order to verify the targeting efficacy. The LNCs
internalization is faster when the NFL is present at their surface. Nevertheless, we
observed that the efficiency depends on different parameters: the amount of NFLs at
LNC surface and also the cellular models.
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